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PURPOSE. Glaucoma is presumed to result in the selective loss of
retinal ganglion cells. In many neural systems, this loss would
initiate a cascade of transneuronal degeneration. The quantifi-
cation of changes in neuronal populations in the middle layers
of the retina can be difficult with conventional histologic
techniques. A method was developed based on multiphoton
imaging of 4,6-diamino-2-phenylindole (DAPI)–stained tissue
to quantify neuron loss in postmortem human glaucomatous
retinas.
METHODS. Retinas from normal and glaucomatous eyes fixed in
4% paraformaldehyde were incubated at 4°C overnight in DAPI
solution. DAPI-labeled neurons at different levels of the retina
were imaged by multiphoton confocal microscopy. Algorithms
were developed for the automated identification of neurons in
the retinal ganglion cell layer (RGCL), inner nucleus layer
(INL), and outer nuclear layer (ONL).
RESULTS. In glaucomatous retinas, the mean density of RGCs
within 4 mm eccentricity was reduced by approximately 45%,
with the greatest RGC loss occurring in a region that corre-
sponds to the central 6° to 14° of vision. Significant neuron loss
in the INL and ONL was also seen at 2 to 4 mm and 2 to 3 mm
eccentricities, respectively. The ratios of neuron densities in
the INL and ONL relative to the RGCL (INL/RGC and ONL/
RGC, respectively) were found to increase significantly at 3 to
4 mm eccentricity.
CONCLUSIONS. The data confirm that the greatest neuronal loss
occurs in the RGCL in human glaucoma. Neuronal loss was also
observed in the outer retinal layers (INL and ONL) that corre-
lated spatially with changes in the RGCL. Further work is
necessary to confirm whether these changes arise from trans-
neuronal degeneration. (Invest Ophthalmol Vis Sci. 2008;49:
1940–1945) DOI:10.1167/iovs.07-0735
The loss of retinal ganglion cells (RGCs) is a key pathologicevent in glaucoma but the extent to which outer retinal
layers are affected remains controversial. In human and exper-
imental glaucoma models, histologic evidence supports neuron
loss in other layers of the retina outside the retinal ganglion cell
layer (RGCL), including the loss of horizontal cells,1 amacrine
cells,2–4 and the associated thinning of the inner nuclear layer
(INL).5,6 Swelling and loss of photoreceptors has also been
reported in patients with high IOP and end-stage glaucoma.7,8
Consistent with these observations, clinical investigations have
shown reduced color sensitivity (particularly in the blue-yellow
axis) in human glaucoma9; in the monkey glaucoma model,
aberrant multifocal electroretinography (mfERG) responses
were seen in both the inner and outer retina10; in DBA2 mice,
thinning of the outer retinal layers correlated with a decrease
in ERG a- and b-wave amplitudes.11 The processes that underlie
neuronal loss in the outer retina remain unclear. It is possible
that they reflect diffuse retinal damage due to the effect of
pressure or retinal ischemia. An alternative explanation is that
the outer retinal damage results from transneuronal degenera-
tion secondary to the loss of RGCs, in which case a gradient of
neural damage (greatest in the inner retina and least in the
outer retina) might be expected. Detailed analysis of the
changes in the neuron populations throughout the retina in
glaucoma is needed to differentiate these possibilities.
Although significant advances have been made in improving
our understanding of retinal neuron topography in human
eyes,12,13 the detection of transneuronal retinal damage is
problematic with conventional imaging techniques such as
Nomarski differential interference contrast (NDIC) optics and
single-photon confocal microscopy. In the present study, mul-
tiphoton confocal microscopy was used to image DAPI labeled
neurons (multiphoton-DAPI method) at defined levels of the
retina. In multiphoton confocal microscopy, there is near-
simultaneous absorption of multiple photons resulting in the
emission of a longer-wavelength light that scatters less and has
a better tissue penetration.14 In addition, the imaging plane is
restricted to a small diffraction-limited focal volume that allows
accurate and high-resolution optical dissection of the retinal
wholemount preparations. With the multiphoton-DAPI ap-
proach, we determined the degree of transretinal degeneration
by quantifying cellular changes in the RGCL, the INL and the
outer nuclear layer (ONL) in normal and glaucomatous human
retinas.
MATERIAL AND METHODS
Retinal Wholemount Preparation
Eyes were retrieved in accordance with the institutional ethics ap-
proval of the Mayo Clinic and University of Washington, St. Louis, and
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the Declaration of Helsinki for research involving human tissue. Six
glaucomatous retinas (61–90 years old) and six age-matched control
retinas (67–83 years old) were used in the study. Detailed clinical
histories were available for the glaucomatous eyes, all of which had
primary open-angle glaucoma (POAG) with IOPs before treatment in
the range of 20 to 30 mm Hg. Although the clinical histories of control
eyes were not available, none was from a patient receiving ophthalmic
care. In all cases, age, gender, ethnic origin, and the cause of death
were known. All postmortem human retinas were fixed in 4% parafor-
maldehyde within 24 hours of death. After the anterior segment and
vitreous humor were removed, the retinas were freed from the retinal
pigment epithelium. Four equal cuts were made in each retina to yield
four approximately equal segments.
Multiphoton-DAPI Imaging
Retinas were stained by DAPI (4,6 diamidino-2-phenylindole; Sigma-
Aldrich, Poole, UK) solution (3 g/mL in PBS) overnight at 4°C and
wholemounted with the RGC side uppermost in a hard-set mounting
medium for fluorescence (Vectashield; Vector Laboratories, Burlin-
game, CA). The specimen was placed on a motorized microscope stage
that allowed the selection of any retinal location to an accuracy of 1
m. DAPI molecules were excited with a Ti-Sapphire multiphoton
laser at 843 nm (Tsunami; Newport SpectraPhysics GmBH, Darmstadt,
Germany), and images were acquired (model TCS SP2; Leica, Milton
Keynes, UK) with a confocal system (DMRE microscope with HCX PL
Apo 40/1.25 NA oil CS objective lens; Leica). Laser power, gain, offset,
and pinhole size of the confocal microscope were kept constant at
each session, to facilitate comparisons between retinas.
To relate retinal disease to clinical data, a sampling grid, which
retinotopically corresponded to the spacing stimuli in a 30-2 visual
field analyser (Humphrey; Carl Zeiss Meditec, Oberkochen Germany)
was used to define sample locations (Fig. 1).15,16 To correlate anatomic
positions on the retina to visual field, we converted the distance (in
millimeters) to degrees of visual angle according to a nonlinear con-
version of retinal magnification factor17 (y  0.035x2 3.4x  0.1,
where y is the eccentricity in arc degrees, and x is in millimeters).
Automated Detection of Cell Nuclei
Neuron nuclei were detected and counted by an established method18
that was implemented as a plug-in in the public domain of ImageJ (ver.
1.34).19 In the projected images of each retinal layer, the average
FIGURE 1. Sampling grid used to quantify neuron populations in the
RGCL, INL, and ONL of the retina. Sample points correspond retino-
topically to the test locations in a Humphrey 30-2 visual field (Carl Zeiss
Meditec, Oberkochen, Germany). The fovea was aligned with the
center of the grid, which was used with optic disc as reference points
in sampling. Points on the grid were 1.7 mm apart (equivalent to 6°
eccentricity). Thirty-six numbered points were selected to collect data,
and unnumbered locations were not sampled.
FIGURE 2. Multiphoton projection
images of DAPI-stained cell nuclei in
the RGCL, INL, and ONL of control
and glaucomatous human retinal
wholemounts. Neuron densities were
measured at the magnification of
400 for neurons in the RGCL, and
1600 for the INL and ONL. Each z-
plane was 10 m thick with a 0.5-m
interval between planes. The projec-
tion image for any given layer was gen-
erated from the sum of the component
z-planes. Scale bar, 20 m.
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nuclei diameters were determined, to give the width threshold in
pixels. Endothelial cells and glial cells were excluded from counting
results by shape and size factors. The multiphoton-DAPI method was
validated against the conventional NDIC method12 by comparing RGC
layer counts of the same specimen. The RGCL neuron density was
corrected for the presence of displaced amacrine cells, to give RGC
densities at different eccentricities of the retina.12,13
Statistics
Statistical analysis was performed with commercial software (SPSS,
ver. 14.0 for Windows; SPSS, Chicago, IL). A general linear model was
used to compare neuron densities and ratios at different eccentricities
of the retina in control and glaucoma groups. For each retinal layer, a
repeated-measures analysis was performed with Bonferroni correction.
Differences were considered significant at a 95% level of confidence
or higher.
RESULTS
At each location of the sampling grid, neurons at the RGCL,
INL, and ONL were imaged sequentially; the projected images
of each layer are shown in Figure 2 of typical control and
glaucomatous retinas. Our estimation of RGC density in the
elderly was 70% of that reported for younger adults, which was
expected, considering the effect of ageing12 (Fig. 3).
Neuron Quantification in the RGCL, INL, and ONL
The retinal areas imaged represented 56% of the total area
within the central 4-mm eccentricity and 27% between 4- and
7-mm eccentricity. In total, 37,425 neurons were counted in
glaucomatous retinas (61–90 years old, n  6) and 57,858 in
age-matched control retinas (67–83 years old, n  6). The
neuron densities were illustrated by color-coded density maps
(Fig. 4). Our data confirmed that RGCL cell density was highest
in the perifoveal region; neuron densities in the INL were
higher in the peripheral relative to the central retina; the peak
density for ONL neurons was at the fovea as expected.
Mean neuron densities in glaucomatous eyes were com-
pared with those in aged-matched control eyes (Fig. 5). In
glaucomatous retinas, there were significant reductions of
RGCs at all eccentricities tested (Fig. 5A); the mean density of
RGCs within 4-mm eccentricity was reduced by approximately
42% (from 13,200–7,700/mm2), with the greatest RGC loss at
2-mm eccentricity (mean  SD, 48%  5%). In the INL and
ONL, significant reductions of neuron densities were recorded
at 2- to 4-mm eccentricity (10%; Fig. 5B; P  0.05) and at 2- to
3-mm eccentricity (7%; Fig. 5C, P  0.05), respectively.
Correlation of Neuron Densities
In view of the variation of neuron densities between retinas,
we expressed the relationship of neuron densities in different
layers of the retina as ratios (e.g., at a given eccentricity), the
INL neurons density divided by the RGCL neuron density
(INL/RGCL, Fig. 6). Within the area examined, the ratios of INL
to RGCL and ONL to RGCL in glaucomatous retinas were
significantly higher than in control retinas between 3 and 4 mm
eccentricity (P  0.05, Figs. 6A, 6B). However, there was no
FIGURE 3. Comparisons of RGC quantities measured by the multiphoton-DAPI method (n  3), with
NDIC optics (n  3), and literature values (n  5). The measurements were taken at nasal, temporal,
superior, and inferior regions of the same retinal wholemounts. Retinas were cleared by DMSO for NDIC
imaging.
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significant difference in the ONL INL ratio in control and
glaucomatous groups at any eccentricity tested (Fig. 6C).
DISCUSSION
The multiphoton-DAPI method allowed us to detect small
changes in the neuronal densities in different layers of the
retina. This technique revealed cell densities that are similar to
those found in previous work taking age into account,12,20
(i.e., on average, RGC counts in the central retina of our aged
normal eyes; 61–90 years old were 30% less than values pub-
lished for younger eyes; 27–37 years); the reduction was great-
est in the nasal and smallest in the inferior retina. We observed
substantial reductions of RGC densities in the glaucomatous
retinas, with the greatest percentage loss occurring in a para-
central distribution. An important finding is that significant
reductions in neuron densities also occurred in the INL (2- to
4-mm eccentricity) and ONL (2- to 3-mm eccentricity) in re-
gions where percentage RGC loss was greatest. Analysis of the
relative ratio of neuron densities at a given eccentricity con-
firms a reduction in both the middle and outer retinal layers.
Our data are consistent with the hypothesis that glaucoma
results in damage to the ONL with consequent photoreceptor
loss. Previous histologic studies in eyes with open-angle glau-
coma have not shown this as a consistent finding. Nork et al.7
reported photoreceptor loss in less than 20% of glaucomatous
retinas with cone perikaryal swelling occurring in only 25% of
those eyes with substantial (90%) RGC loss. It is interesting to
note that the use of more sensitive techniques, such as mea-
surements of red-green and blue cone opsin mRNA, has dem-
onstrated that outer retinal damage is a more consistent feature
in primate glaucoma.21 In our study, RGC loss was moderate at
42% compared with that in control eyes, and yet we found
consistent evidence of outer retinal damage in these eyes. It is
likely that our findings reflect the greater sensitivity of the
multiphoton-DAPI technique in the quantification of neuronal
population throughout a selected retinal volume.
Our observation that the increases in the INL/RGCL and
ONL/RGCL ratios in the glaucomatous eyes coincided with the
region of the greatest RGC loss (Figs. 5, 6) suggests that RGC
loss and outer retinal damage are spatially correlated, and the
INL and ONL damage are not simply the result of nonspecific
FIGURE 4. Color-coded neuron density maps and correlation maps in control and glaucomatous retinas.
The color gradient is assigned to density values and ratios, as shown on the right of each contour plot.
Positions on the contour map correlate with those on the sampling grid. Eccentricities are shown on the
x and y axes in millimeters, and each map is centered on the fovea.
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retinal damage. Our data cannot confirm that transneuronal
effects are responsible for damages in the INL and ONL, but
this should be considered as a factor.
The cause of outer retinal damage remains to be clarified. It
is possible that it reflects the toxic effect of the release of
neurotransmitters such as glutamate. Although it now seems
unlikely that this release will result in toxic neurotransmitter
levels that can be detected in the vitreous,22 local levels may be
elevated to increase the risk of cell loss.23 The importance of
this in the propagation of further cell loss is controversial,
since glutamate uptake mechanisms in experimental glaucoma
do not appear to be compromised.24 Other factors that may
play a role in propagating neuronal loss outside the RGCL layer
include the release of free radicals or alterations in the concen-
tration of extracellular calcium.25–28 At the level of the RGCL,
there is evidence that partial damage to the optic nerve can
increase the risk of loss of other adjacent cells as a bystander
effect.29,30
Our data highlight the importance of transretinal degener-
ation in human glaucoma. Because the outer retinal neurons
are lost, some of these changes are irreversible, which empha-
sizes the importance of developing methods for the detection
of outer retinal damage.31 Neuroprotection in glaucoma is
focused on the prevention of RGC loss in ways that compli-
ment oculohypotensive treatment. Consideration should also
be given to the prevention of outer retinal damage to maximize
the efficacy of this approach.
FIGURE 5. Comparisons of neuron densities in the RGCL (A), INL (B),
and ONL (C) of glaucomatous (n  6) and control (n  6) retinas. The
line graph shows means of neuron densities at each eccentricity, and
the histogram shows means within a 4-mm eccentricity. Error bars, 
1 SD. *P  0.05, **P  0.01.
FIGURE 6. Neuron density ratios of INL to RGCL (A), ONL to RGCL
(B), and ONL to INL (C) in glaucomatous (n  6) and control (n  6)
retinas. Lines show means of neuron density ratios at each eccentricity.
Error bars, 1 SD.
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